Magnus Holmer

Publications
CV
Public outreach and news

Articles

Article: HEPATOLOGY. 2025
Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study.
Holmer M; Ingre M; Färkkilä M; Ponsioen C; Mol B; Schramm C; Folseraas T; Wiencke K; Cazzagon N; Catanzaro E; Molinaro A; Nilsson E; Vessby J; Kechagias S; Nyhlin N; Werner M; Bergquist A
Article: BRITISH JOURNAL OF NUTRITION. 2024;132(4):1-13
Associations between dietary fatty acid and plasma fatty acid composition in non-alcoholic fatty liver disease: secondary analysis from a randomised trial with a hypoenergetic low-carbohydrate high-fat and intermittent fasting diet
Tillander V; Holmer M; Hagstrom H; Petersson S; Brismar TB; Stal P; Lindqvist C
Article: LIVER INTERNATIONAL. 2024;44(5):1253-1264
Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD
Yang W; Ebrahimi F; Romeo S; Holmer M; Vessby J; Ekstedt M; Ludvigsson JF; Shang Y; Hagstrom H
Article: NUTRITION. 2023;110:111982
Macronutrient composition and its effect on body composition changes during weight loss therapy in patients with non-alcoholic fatty liver disease: Secondary analysis of a randomized controlled trial
Lindqvist C; Holmer M; Hagstrom H; Petersson S; Tillander V; Brismar TB; Stal P
Article: LIVER INTERNATIONAL. 2022;42(12):2769-2780
Effect of common genetic variants on the risk of cirrhosis in non-alcoholic fatty liver disease during 20 years of follow-up
Holmer M; Ekstedt M; Nasr P; Zenlander R; Wester A; Tavaglione F; Romeo S; Kechagias S; Stal P; Hagstrom H
Article: SCIENTIFIC REPORTS. 2022;12(1):20519
Associations between subcutaneous adipocyte hypertrophy and nonalcoholic fatty liver disease
Holmer M; Hagstrom H; Chen P; Danielsson O; Aouadi M; Ryden M; Stal P
Article: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 2021;33(11):1420-1426
A personalized treatment program in persons with type 2 diabetes is associated with a reduction in liver steatosis
Bjorkstrom K; Stal P; Holmer M; Bengtsson B; Staaf A; Hoffstedt J; Hagstrom H
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2021;56(6):727-732
Etiologies and outcomes of cirrhosis in a large contemporary cohort
Hagstrom H; Lindfors A; Holmer M; Bengtsson B; Bjorkstrom K; Hegmar H; von Seth E
Article: JHEP REPORTS. 2021;3(3):100256
Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial
Holmer M; Lindqvist C; Petersson S; Moshtaghi-Svensson J; Tillander V; Brismar TB; Hagstrom H; Stal P
Article: LIVER INTERNATIONAL. 2018;38(11):2082-2090
Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries
Holmer M; Melum E; Isoniemi H; Ericzon B-G; Castedal M; Nordin A; Schultz NA; Rasmussen A; Line P-D; Stal P; Bennet W; Hagstrom H

All other publications

Doctoral thesis: 2022
Aspects of diagnosis, prognosis and treatment of nonalcoholic fatty liver disease
Holmer M
Letter: JHEP REPORTS. 2021;3(6):100366
Reply to: "Reduced steatosis and weight as a result of specific diets or the dietitian themselves"
Holmer M; Lindqvist C; Hagstrom H; Stal P

Employments

Affiliated to Research, Department of Medicine, Huddinge, Karolinska Institutet, 2025-2028

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Medicine, Huddinge, Karolinska Institutet, 2022
University Medical Degree, Karolinska Institutet, 2005

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI